|
|
Volumn 267, Issue 24, 1992, Pages 3342-3348
|
|
Cost-effectiveness analysis: Is it up to the task?
a
a
Box 32
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CANCER SCREENING;
CHOLESTEROL BLOOD LEVEL;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
HEALTH CARE COST;
HUMAN;
HYPERCHOLESTEROLEMIA;
MEDICAL PRACTICE;
NOTE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
UTERINE CERVIX CANCER;
ARTICLE;
BONE MARROW TRANSPLANTATION;
BREAST TUMOR;
CANCER;
CLINICAL APPROACH/SOURCE;
COSTS AND BENEFITS;
DECISION SUPPORT SYSTEM;
ECONOMICS;
FEMALE;
FEMALES;
HEALTH CARE;
HEALTH CARE AND PUBLIC HEALTH;
HEALTH CARE ORGANIZATION;
HEALTH CARE PLANNING;
LEGAL ASPECT;
MEDICAID;
PATIENT SELECTION;
RESOURCE ALLOCATION;
SELECTION FOR TREATMENT;
TREATMENT OUTCOME;
UNITED STATES;
CANCER;
CLINICAL APPROACH/SOURCE;
COSTS AND BENEFITS;
FEMALES;
HEALTH CARE;
HEALTH CARE AND PUBLIC HEALTH;
MEDICAID;
OREGON;
RESOURCE ALLOCATION;
SELECTION FOR TREATMENT;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
BONE MARROW TRANSPLANTATION;
BREAST NEOPLASMS;
COST-BENEFIT ANALYSIS;
DECISION SUPPORT TECHNIQUES;
FEMALE;
HEALTH CARE RATIONING;
HEALTH PRIORITIES;
HUMAN;
OREGON;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
PATIENT SELECTION;
SUPPORT, NON-U.S. GOV'T;
UNITED STATES;
|
|
EID: 85037434567
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.1992.03480240112046 Document Type: Note |
|
Times cited : (56)
|
|
References (0)
|
